Insider filing
Traded Dec 3, 2025 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 12, 2025 · Filed Nov 14, 2025
An Exelixis director sold $4.36M of Exelixis shares. The filing references vesting of compensation awards.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$4,355,000
Shares × reported transaction price
8 days after results of Nov 4, 2025, 61 days before results of Jan 12, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $43.59 on Nov 12, 2025, 35% above its 52-week low and 6% below its high, after a 6% rise over the previous 30 trading days
52-week range $32.38 (Jan 24, 2025) to $46.26 (May 15, 2025), 81% of the way up, from 250 adjusted closes. 30 trading days earlier: $41.20 on Oct 1, 2025. Describes the past only, not a forecast
RSI 68, 11% above its 200-day average, 11% above its 50-day average, 6% below the 52-week high, 20-day volatility 62% a year, against the S&P 500: +7 points over 1 month, +7 points over 3 months, −19 points over 6 months
From the adjusted closes up to Nov 12, 2025. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Stelios Papadopoulos's largest sale of EXEL in their filings since 2017
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +2.1% | −1.9% | +4.0% |
| 30 days | −0.7% | +1.3% | −2.0% |
| 90 days | +2.5% | +1.4% | +1.1% |
| 180 days | +23.1% | +10.5% | +12.7% |
| 365 days | +61.1% | +10.1% | +51.0% |
Past results only. Not a forecast.
Insider filing
Traded Dec 3, 2025 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider buying
First insider buy since May 2024Traded Nov 25, 2025 · filed 1 day later
An Exelixis director paid $1.19M out of pocket for Exelixis shares.
Patrick J. Haley (EVP, Commercial) sold ~$421K of Exelixis
Automatic saleEvery dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.